Switching Bupropion SR to XL: Direct Conversion at Same Total Daily Dose
Yes, you can switch directly from bupropion SR to bupropion XL at the same total daily dose without titration or washout. 1
FDA-Approved Switching Protocol
The FDA label explicitly states: "When switching patients from WELLBUTRIN SR sustained-release tablets (bupropion hydrochloride sustained-release tablets (SR)) to bupropion hydrochloride extended-release tablets (XL), give the same total daily dose when possible." 1
Practical Conversion Examples
- 150 mg SR twice daily (300 mg total) → 300 mg XL once daily in the morning 1
- 100 mg SR twice daily (200 mg total) → 150 mg XL once daily (closest available dose) 1
The switch is immediate—no overlap period, no gradual transition, and no dose adjustment required. 1
Bioequivalence Justification
All three bupropion formulations (IR, SR, and XL) are bioequivalent in terms of total systemic exposure to bupropion and its active metabolites, meaning they deliver the same amount of drug to the bloodstream over 24 hours. 2, 3, 4 The only difference lies in the release kinetics:
- SR formulation: Peak plasma concentration at ~3 hours, requiring twice-daily dosing 2
- XL formulation: Peak plasma concentration at ~5 hours, allowing once-daily dosing 2
Because total daily exposure (AUC) is equivalent, switching at the same total daily dose maintains therapeutic drug levels without risk of under- or over-dosing. 2, 3
Timing and Administration
- Administer XL in the morning to minimize insomnia risk 5, 1
- May be taken with or without food 1
- Swallow whole—do not crush, divide, or chew 1
Critical Safety Reminders During the Switch
- Maximum dose limits remain unchanged: 400 mg/day for SR; 450 mg/day for XL 5
- Seizure risk stays constant at the same total daily dose (~0.1% at ≤300 mg/day) 5
- Monitor blood pressure during the first 12 weeks, as bupropion can elevate BP regardless of formulation 5
- Assess for neuropsychiatric symptoms (agitation, suicidal ideation) in patients <24 years old, especially in weeks 1–2 5
Common Pitfall to Avoid
Do not reduce the dose when switching from SR to XL. Some clinicians mistakenly lower the total daily dose out of concern for the once-daily formulation, but this is unnecessary and risks loss of antidepressant efficacy. 5 The FDA and all bioequivalence data support same-dose conversion. 1, 2
Historical Context on Generic Bioequivalence
Older generic versions of bupropion SR (pre-2012) had documented bioequivalence failures compared to brand-name Wellbutrin SR, leading to loss of efficacy in some patients. 5 However, this issue does not apply to brand-to-brand switches (e.g., Wellbutrin SR to Wellbutrin XL) or to current FDA-approved generics that meet bioequivalence standards. 5 If switching between brand and generic formulations, monitor closely for 4–6 weeks. 5